Nature of change: Appointment of additional Non-Executive Independent Director
Name and DIN: Mr. Hemant Maheshwari (DIN: 06771309)
Effective date: June 23, 2026 (subject to shareholder approval)
Term: Appointment is for a period until the ensuing Annual General Meeting [as per standard practice for director appointments requiring shareholder ratification]
Qualifications: Fellow Member of The Institute of Company Secretaries of India (ICSI), Commerce Graduate from Maharaja Ganga Singh University
Expertise: Over 14 years of experience in corporate laws, regulatory compliance, governance matters, securities laws, and capital market transactions. Specific expertise includes advisory and implementation under Companies Act 2013, SEBI Regulations, FEMA, RBI/NBFC regulations, and listing compliances
Profile: Founder of H. Maheshwari & Associates, a Corporate Secretarial and Regulatory Advisory Firm. Brings independent, analytical approach focused on transparency, accountability, and long-term stakeholder value
Relationship with other directors: Not related to any director on the Board of the Company
Other directorships:
Harrison Med-Pharma Private Limited
H. Maheshwari & Associates (as Founder)
Governance implications: The appointment strengthens the independent director composition and brings specialized expertise in regulatory compliance and corporate governance to the steel manufacturing company
Key Financial or Operational Approvals
Not applicable - disclosure solely concerns director appointment
Strategic or Business Context
Not applicable - no strategic or business context provided in the disclosure
Any Other Material Information
Regulatory compliance: Disclosure made pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, and SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026
Board meeting: Held on Tuesday, June 23, 2026 at the Registered Office of the Company
